Galway headquartered pharmaceutical company Chanelle Pharma has announced Angelo Gatto as its new CEO.
Mr Gatto has held operational, commercial and management roles at Johnson & Johnson, Pfizer, Aenova Group, and most recently, Adragos Pharma.
In February 2024, Chanelle Pharma was acquired by Exponent, a European private equity firm.
Having played a key role on Exponent’s advisory team at the time of its investment in the company, he now joins the business with immediate effect to lead the next phase of its growth.
"Angelo brings relevant experience in all our business areas, and has demonstrated remarkable excellence throughout his entire career," said Carsten Hellmann, Chairman of Chanelle Pharma.
"I am confident in his ability to lead Chanelle Pharma through this exciting next chapter," he added.
Mr Gatto said he looks forward to working closely with the team.
"Chanelle Pharma has built an incredible brand with strong foundations and a unique positioning for "one-health" which focuses on both human and animal health," he said.
Chanelle Pharma is Ireland's largest manufacturer of generic pharmaceuticals for human and animal health.
It employs more than 700 people in Ireland, the UK, Portugal and Jordan.
Headquartered in Loughrea, its global supply chain and distribution network exports to over 80 countries.
